These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 17485579

  • 21. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
    Klein G, Lissel C, Fuchs AC, Gardiwal A, Oswald H, Desousa M, Pichlmaier AM, Lichtinghagen R, Geerlings H, Lippolt P, Niehaus M, Drexler H, Korte T.
    Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615
    [Abstract] [Full Text] [Related]

  • 22. Reduced ejection fraction, sudden cardiac death, and heart failure death in the mode selection trial (MOST): implications for device selection in elderly patients with sinus node disease.
    Sweeney MO, Hellkamp AS, Ellenbogen KA, Lamas GA.
    J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1160-6. PubMed ID: 18554201
    [Abstract] [Full Text] [Related]

  • 23. A guide to device selection: cardiac resynchronization therapy alone or in combination with an implantable cardioverter defibrillator.
    Prystowsky EN.
    Rev Cardiovasc Med; 2003 Nov; 4 Suppl 2():S47-54. PubMed ID: 12776013
    [Abstract] [Full Text] [Related]

  • 24. Electrophysiological study and 'slow' ventricular tachycardia predict appropriate therapy: results from a single-centre implantable cardiac defibrillator follow-up.
    Worck R, Haarbo J, Thomsen PE.
    Europace; 2007 Nov; 9(11):1048-53. PubMed ID: 17686794
    [Abstract] [Full Text] [Related]

  • 25. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.
    Healey JS, Hallstrom AP, Kuck KH, Nair G, Schron EP, Roberts RS, Morillo CA, Connolly SJ.
    Eur Heart J; 2007 Jul; 28(14):1746-9. PubMed ID: 17283003
    [Abstract] [Full Text] [Related]

  • 26. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S.
    Circulation; 2008 Apr 15; 117(15):1918-26. PubMed ID: 18391108
    [Abstract] [Full Text] [Related]

  • 27. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
    Healey JS, Hohnloser SH, Exner DV, Birnie DH, Parkash R, Connolly SJ, Krahn AD, Simpson CS, Thibault B, Basta M, Philippon F, Dorian P, Nair GM, Sivakumaran S, Yetisir E, Wells GA, Tang AS, RAFT Investigators.
    Circ Heart Fail; 2012 Sep 01; 5(5):566-70. PubMed ID: 22896584
    [Abstract] [Full Text] [Related]

  • 28. Mortality and cause of death in patients with chronic non-rheumatic atrial fibrillation after a two-year follow-up.
    Scardi S, Mazzone C, Pandullo C, Goldstein D, Di Lenarda A, Chersevani D.
    G Ital Cardiol; 1999 Jun 01; 29(6):637-46. PubMed ID: 10396667
    [Abstract] [Full Text] [Related]

  • 29. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
    Connolly SJ, Crijns HJ, Torp-Pedersen C, van Eickels M, Gaudin C, Page RL, Hohnloser SH, ATHENA Investigators.
    Circulation; 2009 Sep 29; 120(13):1174-80. PubMed ID: 19752319
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Incidence of thromboembolic events in congestive heart failure. The V-HeFT VA Cooperative Studies Group.
    Dunkman WB, Johnson GR, Carson PE, Bhat G, Farrell L, Cohn JN.
    Circulation; 1993 Jun 29; 87(6 Suppl):VI94-101. PubMed ID: 8500246
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial.
    Mooss AN, Wurdeman RL, Sugimoto JT, Packard KA, Hilleman DE, Lenz TL, Rovang KS, Arcidi JM, Mohiuddin SM.
    Am Heart J; 2004 Oct 29; 148(4):641-8. PubMed ID: 15459595
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
    Fishbein DP, Hellkamp AS, Mark DB, Walsh MN, Poole JE, Anderson J, Johnson G, Lee KL, Bardy GH, SCD-HeFT Investigators.
    J Am Coll Cardiol; 2014 Jun 17; 63(23):2560-2568. PubMed ID: 24727258
    [Abstract] [Full Text] [Related]

  • 39. Mechanism of death in heart failure. The Vasodilator-Heart Failure Trials. The V-HeFT VA Cooperative Studies Group.
    Goldman S, Johnson G, Cohn JN, Cintron G, Smith R, Francis G.
    Circulation; 1993 Jun 17; 87(6 Suppl):VI24-31. PubMed ID: 8500236
    [Abstract] [Full Text] [Related]

  • 40. Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial.
    Uretsky BF, Thygesen K, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, Cleland JG.
    J Card Fail; 2008 Oct 17; 14(8):670-5. PubMed ID: 18926439
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.